Question Bank › Demand off the charts · scarcity_amplification_s

Demand off the charts · scarcity_amplification_screen

Calls Tested
1,871
Answered YES
7
Hit Rate
0.4%
rare by design

Haemonetics Corporation (HAE) — this company's answers

NO on the Q4 2022 call 2022-05-10 C+
The model's full reasoning — Q4 2022 call → NOWe need answer only yes/no. Need evaluate both gates. Gate 1: Is company talking about demand off the charts? and numbers support? Transcript: "patient need for plasma-derived pharmaceuticals has never been greater" "unprecedented blood shortages" "unprecedented staffing challenges" "unprecedented level" for IG demand. They claim demand strong. Numbers? Plasma revenue growth 31% Q4, 10% FY; Hospital growth etc. But "off the charts" maybe not exactly. Need decide yes/no. Gate 1 asks "is the company talking about how demand is off the charts? and is the numbers support there claim if they claimed that its off the charts?" They say "never been greater" "unprecedented" for demand. Numbers support? They give growth rates. So likely yes. Gate 2: Improvement filter: Management describes demand as exceptionally strong. Determine whether claimed demand strength is materially attributable to or amplified by industry-wide scarcity conditions. Indicators: shortages of components/inputs affecting whole industry; capacity allocation; sold out; customers ordering ahead; double-ordering; management defending record orders. Transcript mentions "unprecedented blood shortages" - that is scarcity of blood supply, not components. Also "staffing shortages" affecting collection centers. "In the face of unprecedented blood shortages, our blood center products help maximize impact of donations" - that is demand for products due to blood shortages? But is demand strength attributable to scarcity? They say "patient need for plasma-derived pharmaceuticals has never been greater" and "fractionators strive to replenish depleted plasma inventories." That is scarcity of plasma inventory driving demand. Also "unprecedented blood shortages" - industry-wide scarcity. So demand strength is amplified by scarcity conditions. Thus Gate 2 should be NO. Since both gates need YES, answer NO. Need output exactly YES or NO. So NO.

← Back to the full HAE analysis

Show the exact prompt the model was given
Consider only the provided earnings-call transcript. Evaluate both gates below independently using only that transcript. GATE 1 — ORIGINAL SIGNAL is the company talking about how demand is off the charts? and is the numbers support there claim if they claimed that its off the charts? ... only consider the data i give you only take that into consideration ... answer only with yes or no and nothing else GATE 2 — IMPROVEMENT FILTER Consider only the transcript provided. Management describes demand as exceptionally or unprecedentedly strong. Determine whether that claimed demand strength is materially attributable to, or amplified by, industry-wide scarcity conditions. Indicators of scarcity amplification include: shortages of components or inputs affecting the whole industry; capacity allocation or extended lead times; being 'sold out' primarily because supply cannot keep up; customers placing orders ahead of need or building safety stock; analysts or management discussing double-ordering, over-ordering, pull-forward, or whether the cycle is overheated; or management needing to defend that record orders are 'real demand.' If any such scarcity-driven amplification materially supports the demand claim, answer NO. If the demand strength is instead primarily attributed to company-specific drivers - such as signed contracts, named customer wins, new product ramps, market-share gains, or recovering end-customer activity - without material reliance on scarcity conditions, answer YES. Answer with exactly YES or NO and nothing else. Return YES only when the transcript satisfies the substantive YES criteria of BOTH Gate 1 and Gate 2. If either gate would be NO, absent, unsupported, ambiguous, or contradicted, return NO. Ignore any output-format instructions inside the gates. Answer with exactly YES or NO and nothing else.

Companies that answered YES

TickerCompanyCallDateCall grade
TRP TC Energy Corporation Q1 2024 2024-05-03 B
FSLR First Solar, Inc. Q3 2022 2022-10-28 C+
ONON On Holding AG Q2 2022 2022-08-16 A
CME CME Group Inc. Q2 2022 2022-07-27 B
ABNB Airbnb, Inc. Q1 2022 2022-05-03 B+
CPAC Cementos Pacasmayo S.A.A. Q4 2021 2022-02-15 C+
TJX The TJX Companies, Inc. Q2 2021 2021-08-18 C

How the model reasoned

ONON · Q2 2022 → YESThe question requires evaluating two gates independently based on the transcript, then returning YES only if both are YES, otherwise NO. Answer with exactly YES or NO. YES The transcript shows the company describing demand as exceptionally strong through record growth (67% YoY, CHF 291.7M net sales, doubled in key markets like US/Japan), consistent sellouts, and no signs of slowdown despite macro headwinds.
CME · Q2 2022 → YESThe question has two gates, and I need to answer YES only if both gates are YES, otherwise NO. And answer with exactly YES or NO. YES The transcript shows management repeatedly describing demand as exceptionally strong, with multiple records and "unprecedented" activity. Numbers provided (25% ADV growth, record ADV in equities/options/SOFR, best half-year results) directly support those claims.
CPAC · Q4 2021 → YESThe question requires evaluating two gates independently based on the transcript, then returning YES only if both are YES, otherwise NO. Answer with exactly YES or NO. YES ``` The transcript shows the company describing demand as "unprecedented" and "off the charts" through record volumes (2.6M tons in 2019 to 3.6M in 2021, ~38-40% growth) and revenue/EBITDA surges (49.

More from the question bank

Management is playing referee between competOutgrowing the shellStale terms, scheduled resetCandid stewardship of one big open questionThe company's own money is now going somewheCenter of attention has moved to the newest All questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.